Cite
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
MLA
Beek, Nina van, et al. “Efficacy and Safety of Adjuvant Immunoadsorption in Pemphigus Vulgaris and Pemphigus Foliaceus (IA-Pem Study): A Multicentre Randomized Controlled Trial.” British Journal of Dermatology, vol. 190, no. 5, May 2024, pp. 657–67. EBSCOhost, https://doi.org/10.1093/bjd/ljad489.
APA
Beek, N. van, Eming, R., Reuss, A., Zillikens, D., Sárdy, M., Günther, C., Kiritsi, D., Benoit, S., Beissert, S., Gläser, R., Gollnick, H., Horváth, O. N., Pfeiffer, C., Röcken, M., Schauer, F., Schreml, S., Steinbrink, K., Zink, A., Schade-Brittinger, C., & Hertl, M. (2024). Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial. British Journal of Dermatology, 190(5), 657–667. https://doi.org/10.1093/bjd/ljad489
Chicago
Beek, Nina van, Rüdiger Eming, Alexander Reuss, Detlef Zillikens, Miklós Sárdy, Claudia Günther, Dimitra Kiritsi, et al. 2024. “Efficacy and Safety of Adjuvant Immunoadsorption in Pemphigus Vulgaris and Pemphigus Foliaceus (IA-Pem Study): A Multicentre Randomized Controlled Trial.” British Journal of Dermatology 190 (5): 657–67. doi:10.1093/bjd/ljad489.